MX2009013753A - Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles. - Google Patents

Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.

Info

Publication number
MX2009013753A
MX2009013753A MX2009013753A MX2009013753A MX2009013753A MX 2009013753 A MX2009013753 A MX 2009013753A MX 2009013753 A MX2009013753 A MX 2009013753A MX 2009013753 A MX2009013753 A MX 2009013753A MX 2009013753 A MX2009013753 A MX 2009013753A
Authority
MX
Mexico
Prior art keywords
regioselective
azabenzimidazoles
benzimidazoles
copper catalyzed
catalyzed synthesis
Prior art date
Application number
MX2009013753A
Other languages
English (en)
Spanish (es)
Inventor
Matthias Urmann
Marc Nazare
Nis Halland
Andreas Lindenschmidt
Jorge Alonso
Omar R Kyek
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2009013753A publication Critical patent/MX2009013753A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2009013753A 2007-06-26 2008-06-11 Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles. MX2009013753A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290800 2007-06-26
PCT/EP2008/004639 WO2009000413A1 (en) 2007-06-26 2008-06-11 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles

Publications (1)

Publication Number Publication Date
MX2009013753A true MX2009013753A (es) 2010-01-26

Family

ID=38646504

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013753A MX2009013753A (es) 2007-06-26 2008-06-11 Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.

Country Status (12)

Country Link
US (1) US8735586B2 (enExample)
EP (1) EP2173721B1 (enExample)
JP (1) JP5492770B2 (enExample)
KR (1) KR20100023907A (enExample)
CN (1) CN101687815A (enExample)
AT (1) ATE539063T1 (enExample)
AU (1) AU2008267444A1 (enExample)
BR (1) BRPI0813271A2 (enExample)
CA (1) CA2691857A1 (enExample)
IL (1) IL202823A0 (enExample)
MX (1) MX2009013753A (enExample)
WO (1) WO2009000413A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
CA2785536C (en) 2009-12-30 2018-02-27 Arqule, Inc. Substituted imidazopyridinyl-aminopyridine compounds
JP5894161B2 (ja) * 2010-08-25 2016-03-23 ネオファーム カンパニー, リミテッド 新規の複素環化合物及びこれを用いた炎症性疾患治療用組成物
ES2616238T3 (es) 2010-10-06 2017-06-12 Glaxosmithkline Llc, Corporation Service Company Derivados de bencimidazol como inhibidores de PI3 quinasa
CN103582632B (zh) 2011-03-31 2015-08-19 拜耳知识产权有限责任公司 取代的苯并咪唑
JP6046710B2 (ja) 2011-06-24 2016-12-21 アーキュール,インコーポレイティド 置換されたイミダゾピリジニル−アミノピリジン化合物
US8815854B2 (en) 2011-06-24 2014-08-26 Arqule, Inc. Substituted imidazopyridinyl compounds
US9156838B2 (en) * 2012-06-22 2015-10-13 Sumitomo Chemical Company, Limited Fused heterocyclic compound
CN102924460B (zh) * 2012-11-05 2015-12-16 南京师范大学 一种4H-吡咯并[1,2-a]苯并咪唑衍生物及其合成方法和应用
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
CN103130811B (zh) * 2013-03-11 2015-02-25 河南师范大学 一种5,6-二氢吡唑并[1,5-c]喹唑啉类化合物的合成方法
AR095604A1 (es) 2013-03-15 2015-10-28 Syngenta Participations Ag Derivados de imidazopiridina útiles como microbicidas
WO2014151367A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv 1,2,5-substituted benzimidazoles as flap modulators
WO2014151380A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv 1,2,6-substituted benzimidazoles as flap modulators
SG11201510409QA (en) 2013-06-21 2016-01-28 Zenith Epigenetics Corp Novel bicyclic bromodomain inhibitors
CA2915622C (en) 2013-06-21 2020-08-18 Zenith Epigenetics Corp. Novel substituted bicyclic compounds as bromodomain inhibitors
US9855271B2 (en) 2013-07-31 2018-01-02 Zenith Epigenetics Ltd. Quinazolinones as bromodomain inhibitors
WO2015077572A1 (en) 2013-11-22 2015-05-28 CL BioSciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
CN103965136B (zh) * 2014-05-07 2016-09-07 苏州波菲特新材料科技有限公司 一种制备n-甲基噻唑啉-2-酮类化合物的方法
EP3227281A4 (en) 2014-12-01 2018-05-30 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
US10179125B2 (en) 2014-12-01 2019-01-15 Zenith Epigenetics Ltd. Substituted pyridines as bromodomain inhibitors
HK1245248B (en) 2014-12-11 2020-05-15 恒翼生物医药(上海)股份有限公司 Substituted heterocycles as bromodomain inhibitors
HK1245247A1 (zh) 2014-12-17 2018-08-24 恒翼生物医药科技(上海)有限公司 溴结构域的抑制剂
SG11201804098TA (en) 2015-11-20 2018-06-28 Forma Therapeutics Inc Purinones as ubiquitin-specific protease 1 inhibitors
CN106519250A (zh) * 2016-09-29 2017-03-22 辽宁石油化工大学 含氮小分子有机配体调节荧光发射性质的一维链状铜配位聚合物的制备方法
GB201617630D0 (en) 2016-10-18 2016-11-30 Cellcentric Ltd Pharmaceutical compounds
EP3562487B1 (en) 2016-12-29 2023-11-29 Ji Xing Pharmaceuticals Hong Kong Limited Metalloenzyme inhibitor compounds
WO2018125799A2 (en) 2016-12-29 2018-07-05 Viamet Pharmaceuticals (Bermuda), Ltd. Metalloenzyme inhibitor compounds
MX388196B (es) 2017-04-26 2025-03-19 Basilea Pharm Int Ag Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
JP7277431B2 (ja) 2017-07-11 2023-05-19 バーテックス ファーマシューティカルズ インコーポレイテッド ナトリウムチャネルのモジュレーターとしてのカルボキサミド
AU2018334272B2 (en) 2017-09-15 2023-06-15 Forma Therapeutics, Inc. Tetrahydro-imidazo quinoline compositions as CBP/p300 inhibitors
GB201800688D0 (en) 2018-01-16 2018-02-28 Redag Crop Prot Ltd Agricultural chemicals
GB201806320D0 (en) 2018-04-18 2018-05-30 Cellcentric Ltd Process
KR102805503B1 (ko) 2018-06-29 2025-05-09 포르마 세라퓨틱스 인크. Creb 결합 단백질(cbp)의 저해
IL316875A (en) 2018-10-05 2025-01-01 Annapurna Bio Inc Compounds and compositions for treating conditions associated with APJ receptor activity
US12358893B2 (en) 2019-01-08 2025-07-15 Corxel Pharmaceuticals Hong Kong Limited Metalloenzyme inhibitor compounds
US12440481B2 (en) 2019-01-10 2025-10-14 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
WO2020146682A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
US12351577B2 (en) 2019-03-15 2025-07-08 Forma Therapeutics, Inc. Inhibiting cyclic AMP-responsive element-binding protein (CREB)
CN110982806B (zh) * 2019-08-30 2022-09-02 浙江工业大学 一种蛋白质芳基衍生物及其制备方法
PH12022551379A1 (en) 2019-12-06 2023-05-03 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
CN111206260B (zh) * 2020-02-12 2022-03-22 齐鲁工业大学 一种吡啶并[1,2-a]苯并咪唑类化合物的电化学合成方法
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
DK4347031T3 (da) 2021-06-04 2025-12-01 Vertex Pharma N-(hydroxyalkyl-(hetero)aryl)-tetrahydrofuran-carboxamider som modulatorer af natriumkanaler

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101088247B1 (ko) * 2005-12-19 2011-11-30 라퀄리아 파마 인코포레이티드 크로메인 치환된 벤즈이미다졸 및 이들의 산 펌프억제제로서의 용도
KR20090097908A (ko) * 2006-12-06 2009-09-16 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도

Also Published As

Publication number Publication date
KR20100023907A (ko) 2010-03-04
IL202823A0 (en) 2010-06-30
CA2691857A1 (en) 2008-12-31
JP5492770B2 (ja) 2014-05-14
ATE539063T1 (de) 2012-01-15
BRPI0813271A2 (pt) 2014-12-30
US20100261909A1 (en) 2010-10-14
AU2008267444A1 (en) 2008-12-31
EP2173721B1 (en) 2011-12-28
WO2009000413A1 (en) 2008-12-31
JP2010531313A (ja) 2010-09-24
CN101687815A (zh) 2010-03-31
EP2173721A1 (en) 2010-04-14
US8735586B2 (en) 2014-05-27

Similar Documents

Publication Publication Date Title
MX2009013753A (es) Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.
IL196431A0 (en) A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
IL201253A0 (en) A transition metal catalyzed synthesis of n - aminoindoles
MX2009014203A (es) Una sintesis de 2h-indazoles catalizada por un metal de transicion.
BRPI0813273A2 (pt) Síntese catalisada por metal regiosseletivo de benzimidazóis e azabenzimidazóis anelados
MX2009013591A (es) Proceso para la preparacion de pirazoles.
MX342850B (es) Proceso para la preparacion de triazolonas quirales.
MX2009013738A (es) Un procedimiento catalizado por paladio para el acoplamiento de alquinos terminales con tosilatos de arilo.
MY162033A (en) New process for the synthesis of agomelatine
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MX2009008772A (es) Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion.
Joshi et al. Synthesis and evaluation of novel benzimidazole derivatives as antimicrobial agents
MY149070A (en) 1h-quinazoline-2,4-diones
MY144746A (en) Process for the preparation of agomelatine
IL200323A0 (en) Synthesis of glyt-1 inhibitors
WO2011012620A3 (en) Processes for the alkylation of pyrazoles
GB201104203D0 (en) Chemical process
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
MY151461A (en) A process for the palladium-catalyzed coupling of terminal alkynes with heteroayl tosylates and heteroaryl benzenesulfonates
MX2009011926A (es) Metodo para la sintesis del acido (z)-3-[2-butoxi-3´-(3-heptil-1-m etil-ureido)-bifenil-4-il]-2-metoxi-acrilico.
WO2008087736A1 (ja) アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法
TH138122A (th) กรรมวิธีการสังเคราะห์สารอนุพันธ์ของไกลโคซิลไตรอะโซล (Glycosyl Triazole) โดยปฏิกิริยาวันพอทโอไกลโคซิเลชั่นคลิกเคมิสทรี (One-pot O-Glycosylation Click Chemistry) (One-pot synthetic method of Glycosyl triazole derivatives)
NO20075687L (no) Fremgangsmate for fremstilling av bicykliske forbindelser
GB0713566D0 (en) The Synthesis of,N-alkylbis(orciny)phenox AZinones;N-alkyl 3,6-D1(1'3'-Dihydroxy-5'-methylbenzene 6')4,5-Dimethylphenoxazin-2-one-7-oxides
TN2009000302A1 (fr) Nouveau procede de synthese de l'agomelatine

Legal Events

Date Code Title Description
FG Grant or registration